Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03956381 · ClinicalTrials.gov registry record
Accuracy of OPS™ Femoral Neck Resection Study
A clinical trial, sponsored by Corin.
- Completed
- Registry status
- 55
- Enrollment target
NCT03956381: Completed study, sponsored by Corin.
NCT03956381 is a clinical trial that has completed, run by Corin. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03956381 has completed, sponsored by Corin.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the accuracy of the Optimized Positioning System (OPS™) planning and delivery tools using different types of surgical approaches.
Primary Outcome
Accuracy of the final osteotomy level compared to the selected OPS™ plan (+ or - 3mm). Two standard of care post-operative x-rays taken at 6 weeks will be used to evaluate the positioning of the total hip prosthesis from the resultant level of resection of the femoral neck. This parameter will be measured in mm.
Interventions
- DEVICE Primary Total Hip Replacement with Trinity cup and TriFit TS stem via posterolateral surgical approach.
- DEVICE Primary Total Hip Replacement with Trinity cup and MetaFix stem via direct anterior surgical approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2019-04-24 |
| Est. Completion | 2021-07-31 |
What the finished NCT03956381 record still lists
NCT03956381 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Primary Total Hip Replacement with Trinity cup and TriFit TS stem via posterolateral surgical approach. is the first listed.
NCT03956381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03956381 about?
NCT03956381 is a clinical study titled "Accuracy of OPS™ Femoral Neck Resection Study". The primary objective of this study is to determine the accuracy of the Optimized Positioning System (OPS™) planning and delivery tools using different types of surgical approaches.
What is the current status of trial NCT03956381?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2019-04-24. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03956381?
The interventions under investigation include: Primary Total Hip Replacement with Trinity cup and TriFit TS stem via posterolateral surgical approach. (DEVICE), Primary Total Hip Replacement with Trinity cup and MetaFix stem via direct anterior surgical approach (DEVICE).
Who is sponsoring clinical trial NCT03956381?
This trial is sponsored by Corin, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI